• Yuri Deigin - Partial Reprogramming Drug Development for Aging

  • Mar 3 2023
  • Duración: 54 m
  • Podcast

Yuri Deigin - Partial Reprogramming Drug Development for Aging

  • Resumen

  • Yuri Deigin, co-founder of YouthBio Therapeutics, discusses developing rejuvenation gene therapies based on partial reprogramming and his role reinvigorating investigations into the origins of SARS-CoV-2.

    The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics.

    https://www.bioinformaticscro.com/

    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Yuri Deigin - Partial Reprogramming Drug Development for Aging

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.